Display options
Cite
Tanner M. Review: Type 2 diabetes screening does not reduce mortality but treating dysglycemia delays onset of diabetes. Ann Intern Med. 2015;163(6):JC2doi: 10.7326/ACPJC-2015-163-6-002.
Tanner, M. (2015). Review: Type 2 diabetes screening does not reduce mortality but treating dysglycemia delays onset of diabetes. Annals of internal medicine, 163(6), JC2. https://doi.org/10.7326/ACPJC-2015-163-6-002
Tanner, Michael. "Review: Type 2 diabetes screening does not reduce mortality but treating dysglycemia delays onset of diabetes." Annals of internal medicine vol. 163,6 (2015): JC2. doi: https://doi.org/10.7326/ACPJC-2015-163-6-002
Tanner M. Review: Type 2 diabetes screening does not reduce mortality but treating dysglycemia delays onset of diabetes. Ann Intern Med. 2015 Sep 15;163(6):JC2. doi: 10.7326/ACPJC-2015-163-6-002. PMID: 26370029.
Copy Download .nbib Format: NLM
Share it on

Ann Intern Med. 2015 Sep 15;163(6):JC2. doi: 10.7326/ACPJC-2015-163-6-002.

Review: Type 2 diabetes screening does not reduce mortality but treating dysglycemia delays onset of diabetes.

Annals of internal medicine

Michael Tanner

PMID: 26370029 DOI: 10.7326/ACPJC-2015-163-6-002

[No abstract available.]

MeSH terms

Publication Types